- Trials with a EudraCT protocol (60)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (2)
60 result(s) found for: Urethral.
Displaying page 1 of 3.
EudraCT Number: 2018-003532-71 | Sponsor Protocol Number: MC/Ph.III-2019 | Start Date*: 2019-10-29 | |||||||||||
Sponsor Name:MukoCell GmbH | |||||||||||||
Full Title: Efficacy and safety of a tissue-engineered oral mucosa (MukoCell®) vs. native oral mucosa graft urethroplasty in male patients with urethral stricture | |||||||||||||
Medical condition: Urethral stricture | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-002175-11 | Sponsor Protocol Number: 2021-35 | Start Date*: 2022-10-25 |
Sponsor Name:ASSISTANCE PUBLIQUE HOPITAUX DE MARSEILLE | ||
Full Title: Safety and potential effect of innovative treatment by adjuvant injection of stromal vascular Fraction from autologous adipose tissue of URethral stenosis with endoscopic urethrotomy: randomized co... | ||
Medical condition: URethral stenosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: FR (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2008-004858-33 | Sponsor Protocol Number: Version 2.0 (03Nov2010) | Start Date*: 2009-01-09 | |||||||||||
Sponsor Name:University College London | |||||||||||||
Full Title: Open label pilot study to treat women with chronic urinary retention or voiding dysfunction due to a primary disorder of sphincter relaxation (Fowler’s syndrome) with outpatient urethral sphincter ... | |||||||||||||
Medical condition: Primary abnormality of the urethral sphincter or Fowlers Syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-004417-13 | Sponsor Protocol Number: CHUBX2018/65 | Start Date*: 2020-06-02 |
Sponsor Name:CHU de Bordeaux | ||
Full Title: PROSPECTIVE RANDOMIZED CLINICAL TRIAL OF EARLY OXYBUTININ TREATMENT FOR BOYS WITH POSTERIOR URETHRAL VALVES | ||
Medical condition: POSTERIOR URETHRAL VALVES | ||
Disease: | ||
Population Age: Infants and toddlers, Under 18 | Gender: Male | |
Trial protocol: FR (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2004-001559-12 | Sponsor Protocol Number: A6061024 | Start Date*: 2005-08-01 | |||||||||||
Sponsor Name:Pfizer | |||||||||||||
Full Title: Measurement of Urethral Function in Women with Stress Urinary Incontinence - Evaluation of the Sensitivity of Urethral Reflectometry compared to Urethral Pressure Profilometry, using [S,S]-Reboxeti... | |||||||||||||
Medical condition: Stress Urinary Incontinence (SUI) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-005839-76 | Sponsor Protocol Number: PDE5I-UPR-AAR-01 | Start Date*: 2021-02-15 | |||||||||||
Sponsor Name:University hospital Bispebjerg and Frederiksberg, Department of Clinical Pharmacology | |||||||||||||
Full Title: Effects of single dose tadalafil on urethral and anal closure function and on urinary flow in healthy females: A randomised, controlled, double-blinded, two-period cross-over study | |||||||||||||
Medical condition: Urinary stress incontinence and fecal incontinence | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-021867-34 | Sponsor Protocol Number: IC-01-01-5-006 | Start Date*: 2011-12-07 | |||||||||||
Sponsor Name:Innovacell Biotechnologie AG - Life Science Center Innsbruck | |||||||||||||
Full Title: An open, multicenter study to evaluate the urodynamic properties of a local implantation of autologous skeletal muscle-derived cells (SMDCs) in female patients with stress urinary incontinence | |||||||||||||
Medical condition: Stress urinary incontinence (SUI) in female patients with predominantly intrinsic sphincter deficiency of moderate severity (Grade 2 and Grade 3) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: SI (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-000361-78 | Sponsor Protocol Number: HTA-HUR-01 | Start Date*: 2020-12-01 |
Sponsor Name:HOLOSTEM TERAPIE AVANZATE S.R.L. | ||
Full Title: PROSPECTIVE, OPEN-LABEL, UNCONTROLLED CLINICAL TRIAL TO ASSESS THE SAFETY AND EFFICACY OF AUTOLOGOUS CULTURED ORAL MUCOSA GRAFTS FOR URETHRAL RECONSTRUCTION IN PATIENTS DUE TO HYPOSPADIAS TREATMENT... | ||
Medical condition: Urethral reconstruction in patients due to hypospadias treatment failure. | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male | |
Trial protocol: IT (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2019-000990-22 | Sponsor Protocol Number: STI_Zoli001 | Start Date*: Information not available in EudraCT |
Sponsor Name:GARDP FOUNDATION | ||
Full Title: A MULTI-CENTER, RANDOMIZED, OPEN-LABEL, NON INFERIORITY TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A SINGLE, ORAL DOSE OF ZOLIFLODACIN COMPARED TO A COMBINATION OF A SINGLE INTRAMUSCULAR DOSE OF ... | ||
Medical condition: Uncomplicated gonorrhoea | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-004040-36 | Sponsor Protocol Number: CE01-302 | Start Date*: 2014-10-10 |
Sponsor Name:Cempra Pharmaceuticals, Inc. | ||
Full Title: A Study to Evaluate the Efficacy and Safety of Oral Solithromycin Compared to Intramuscular Ceftriaxone Plus Oral Azithromycin in the Treatment of Patients With Gonorrhea (SOLITAIRE-U). | ||
Medical condition: gonorrhoea | ||
Disease: | ||
Population Age: Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: (No results available) |
EudraCT Number: 2008-005350-21 | Sponsor Protocol Number: A0221064 | Start Date*: 2009-02-03 | |||||||||||
Sponsor Name:Pfizer Limited, Ramsgate Road, Sandwich, Kent CT13 9NJ, UK | |||||||||||||
Full Title: A PHASE 2, RANDOMIZED, DOUBLE-BLIND, MULTI-DOSE, PLACEBO-CONTROLLED CROSSOVER STUDY OF THE EFFICACY OF FESOTERODINE IN INCREASING URETHRAL PRESSURE IN STRESS URINARY INCONTINENCE PATIENTS | |||||||||||||
Medical condition: Stress urinary incontinence | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-023686-22 | Sponsor Protocol Number: 2010.608 | Start Date*: 2011-03-09 | |||||||||||
Sponsor Name:Hospices Civils de Lyon | |||||||||||||
Full Title: Traitement préopératoire des hypospades sévères par oestrogènes locaux versus placebo : effet sur les défauts de cicatrisation post opératoires | |||||||||||||
Medical condition: Hypospade | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004296-22 | Sponsor Protocol Number: 2014-RdC-PRO-Th | Start Date*: 2015-11-10 | |||||||||||
Sponsor Name:Centre Eugène Marquis | |||||||||||||
Full Title: Anticholinergics impact in the treatment of acute irritative urinary toxicity during radiotherapy for prostate cancer | |||||||||||||
Medical condition: Symptomatology related to acute urinary toxicity occuring during prostate irradiation in patients suffering from prostate cancer. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: FR (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-020397-42 | Sponsor Protocol Number: UROL2008/5 | Start Date*: 2010-12-22 |
Sponsor Name:VUmc Dept Urology | ||
Full Title: The efficacy of an antigenic marker lesion for the therapeutic effect in patients with multiple, Ta/T1, G1/G2, non-muscle invasive bladder cancer (NMIBC) treated with TUR followed by IL-2 instillation | ||
Medical condition: Multiple, Ta / T1, G1 / G2, non-muscle invasive bladder carcinoma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-000931-16 | Sponsor Protocol Number: 1054 | Start Date*: 2008-08-05 |
Sponsor Name:Dr G I Hackett | ||
Full Title: 1054 -FINAL VERSION 30th Dec 2007 Clinical and biochemical improvement in Type 2 diabetic parameters in type 2 diabetic men with symptomatic testosterone deficiency syndrome (TDS). A double blind... | ||
Medical condition: Male Type 2 diabetics with symptomatic testosterone deficiency and confirmed low levels of serum testosterone | ||
Disease: | ||
Population Age: | Gender: | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2021-006371-42 | Sponsor Protocol Number: 16112021 | Start Date*: 2022-02-15 | |||||||||||
Sponsor Name:Hanna-Reeta Viljamaa | |||||||||||||
Full Title: Lasten vesikoureteraalisen refluksin diagnosointi isotooppimiktiokystografia- ja kontrastiaine UÄ-tutkimuksilla | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-003244-13 | Sponsor Protocol Number: D4280C00016 | Start Date*: 2015-04-17 | |||||||||||
Sponsor Name:Pfizer Inc. | |||||||||||||
Full Title: A single blind, randomised, multi-centre, active controlled, trial to evaluate safety, tolerability, pharmacokinetics and efficacy of ceftazidime and avibactam compared with cefepime in children fr... | |||||||||||||
Medical condition: Complicated urinary tract infections | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) CZ (Completed) GR (Completed) PL (Completed) RO (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-002417-35 | Sponsor Protocol Number: NUCOGI-VINGEM | Start Date*: 2013-09-10 | |||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Department of Oncology, Karolinska University Hospital | |||||||||||||||||||||||||||||||||||||||||||
Full Title: A multicenter, randomized phase II trial of vinflunine/gemcitabine versus carboplatin /gemcitabine as first line treatment in patients with metastatic urothelial carcinoma unfit for cisplatin based... | |||||||||||||||||||||||||||||||||||||||||||
Medical condition: Locally advanced or Metastatic urothelial carcinoma | |||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||
Trial protocol: SE (Completed) DK (Completed) FI (Completed) | |||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-002859-16 | Sponsor Protocol Number: BXL628 02 17 | Start Date*: 2007-10-10 | |||||||||||
Sponsor Name:BIOXELL SPA | |||||||||||||
Full Title: A randomized, double blind, placebo controlled, parallel group study to determine the effect of Elocalcitol on sperm parameters in infertile male patients | |||||||||||||
Medical condition: male infertility | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-001548-23 | Sponsor Protocol Number: 1 | Start Date*: 2020-04-02 | ||||||||||||||||
Sponsor Name:Guy's & St Thomas' NHS Foundation Trust | ||||||||||||||||||
Full Title: Does subarachnoid administration of hyperbaric prilocaine produce an improved recovery from anaesthesia when compared with hyperbaric bupivacaine when used to facilitate cervical cerclage in pregna... | ||||||||||||||||||
Medical condition: Cervical cerclage | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
